These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 18072814)

  • 1. Quetiapine: dose-response relationship in schizophrenia.
    Sparshatt A; Jones S; Taylor D
    CNS Drugs; 2008; 22(1):49-68; discussion 69-72. PubMed ID: 18072814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A retrospective study of clinical usage of quetiapine XR and quetiapine IR in outpatients with schizophrenia in Denmark.
    Emborg C; Hallerbäck T; Jörgensen L; Carlborg A
    Hum Psychopharmacol; 2012 Sep; 27(5):492-8. PubMed ID: 22996616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dosing of quetiapine in schizophrenia: how clinical practice differs from registration studies.
    Citrome L; Jaffe A; Levine J; Lindenmayer JP
    J Clin Psychiatry; 2005 Dec; 66(12):1512-6. PubMed ID: 16401150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quetiapine in patients with schizophrenia. A high- and low-dose double-blind comparison with placebo. Seroquel Study Group.
    Small JG; Hirsch SR; Arvanitis LA; Miller BG; Link CG
    Arch Gen Psychiatry; 1997 Jun; 54(6):549-57. PubMed ID: 9193196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple fixed doses of "Seroquel" (quetiapine) in patients with acute exacerbation of schizophrenia: a comparison with haloperidol and placebo. The Seroquel Trial 13 Study Group.
    Arvanitis LA; Miller BG
    Biol Psychiatry; 1997 Aug; 42(4):233-46. PubMed ID: 9270900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dose-response and comparative efficacy and tolerability of quetiapine across psychiatric disorders: a systematic review of the placebo-controlled monotherapy and add-on trials.
    Zhornitsky S; Potvin S; Moteshafi H; Dubreucq S; Rompré PP; Stip E
    Int Clin Psychopharmacol; 2011 Jul; 26(4):183-92. PubMed ID: 21372722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quetiapine : A Review of its Use in Schizophrenia.
    Gunasekara NS; Spencer CM
    CNS Drugs; 1998 Apr; 9(4):325-40. PubMed ID: 27521016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Review of quetiapine and its clinical applications in schizophrenia.
    Kasper S; Müller-Spahn F
    Expert Opin Pharmacother; 2000 May; 1(4):783-801. PubMed ID: 11249516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A positron emission tomography study of quetiapine in schizophrenia: a preliminary finding of an antipsychotic effect with only transiently high dopamine D2 receptor occupancy.
    Kapur S; Zipursky R; Jones C; Shammi CS; Remington G; Seeman P
    Arch Gen Psychiatry; 2000 Jun; 57(6):553-9. PubMed ID: 10839333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and tolerability of once-daily extended release quetiapine fumarate in acute schizophrenia: a randomized, double-blind, placebo-controlled study.
    Kahn RS; Schulz SC; Palazov VD; Reyes EB; Brecher M; Svensson O; Andersson HM; Meulien D;
    J Clin Psychiatry; 2007 Jun; 68(6):832-42. PubMed ID: 17592906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between daily dose, plasma concentrations, dopamine receptor occupancy, and clinical response to quetiapine: a review.
    Sparshatt A; Taylor D; Patel MX; Kapur S
    J Clin Psychiatry; 2011 Aug; 72(8):1108-23. PubMed ID: 21294996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and tolerability of once-daily extended release quetiapine fumarate in acute schizophrenia: pooled data from randomised, double-blind, placebo-controlled studies.
    Meulien D; Huizar K; Brecher M
    Hum Psychopharmacol; 2010 Mar; 25(2):103-15. PubMed ID: 20196185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. D(2) and 5HT(2A) receptor occupancy of different doses of quetiapine in schizophrenia: a PET study.
    Gefvert O; Lundberg T; Wieselgren IM; Bergström M; Långström B; Wiesel F; Lindström L
    Eur Neuropsychopharmacol; 2001 Apr; 11(2):105-10. PubMed ID: 11313155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Olanzapine versus other atypical antipsychotics for schizophrenia.
    Komossa K; Rummel-Kluge C; Hunger H; Schmid F; Schwarz S; Duggan L; Kissling W; Leucht S
    Cochrane Database Syst Rev; 2010 Mar; (3):CD006654. PubMed ID: 20238348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of bd and tid dose regimens of quetiapine (Seroquel) in the treatment of schizophrenia.
    King DJ; Link CG; Kowalcyk B
    Psychopharmacology (Berl); 1998 May; 137(2):139-46. PubMed ID: 9630000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quetiapine: an effective antipsychotic in first-episode schizophrenia despite only transiently high dopamine-2 receptor blockade.
    Tauscher-Wisniewski S; Kapur S; Tauscher J; Jones C; Daskalakis ZJ; Papatheodorou G; Epstein I; Christensen BK; Zipursky RB
    J Clin Psychiatry; 2002 Nov; 63(11):992-7. PubMed ID: 12444812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quetiapine versus other atypical antipsychotics for schizophrenia.
    Asmal L; Flegar SJ; Wang J; Rummel-Kluge C; Komossa K; Leucht S
    Cochrane Database Syst Rev; 2013 Nov; (11):CD006625. PubMed ID: 24249315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The efficacy and safety of once-daily quetiapine extended release in patients with schizophrenia switched from other antipsychotics: an open-label study in Chinese population.
    Pan PY; Lee MS; Yeh CB
    BMC Psychiatry; 2015 Jan; 15():1. PubMed ID: 25609320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Administration of once-daily extended release quetiapine in schizophrenic disorders].
    Bartkó G
    Neuropsychopharmacol Hung; 2007 Dec; 9(4):189-95. PubMed ID: 18510263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quetiapine for schizophrenia.
    Srisurapanont M; Maneeton B; Maneeton N
    Cochrane Database Syst Rev; 2004; 2004(2):CD000967. PubMed ID: 15106155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.